CLINICAL_TRIALS
trial_result
· 2019-03-22
Clinical Trial Update: Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage [Phase 3]
Summary
A Phase 3 trial evaluating antenatal phenobarbital to prevent neonatal intracranial hemorrhage has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 3 | Status: COMPLETED